2025. Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s509. DOI:https://doi.org/10.25251/skin.9.supp.509.